Patent Assignment
Reel/Frame 045129/0795
Assignment of Assignor's Interest
Recorded: 2018-03-07
Pages: 6
Assignor
NOVARTIS PHARMA AG
Executed: 2017-11-15
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties
(2)
Methods and Compositions for Determining the Potency of a Therapeutic Cellular Composition
Patent:
12,566,181 →
Application:
15/913,520 →
Publication:
US 2018/0252729
PCT:
PCT/US2018/021149 ↗
Methods and Compositions for Determining the Potency of a Therapeutic Cellular Composition
Application:
62/467,420 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 7, 2018
From: ILDSTAD, SUZANNE T.
To: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION
Reel/Frame 045129/0448 →
Assignment of Assignor's Interest
Mar 7, 2018
From: NOVARTIS PHARMACEUTICALS CORPORATION
To: NOVARTIS AG
Reel/Frame 045129/0667 →
Assignment of Assignor's Interest
Mar 7, 2018
From: SENYUKOV, VLADIMIR
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 045129/0566 →
Assignment of Assignor's Interest
Mar 7, 2018
From: KATOPODIS, ANDREAS; JESCHKE, MARGIT
To: NOVARTIS PHARMA AG
Reel/Frame 045129/0541 →
Assignment of Assignor's Interest
Nov 5, 2018
From: NOVARTIS AG
To: REGENEREX, LLC
Reel/Frame 047412/0738 →
Change of Name
Aug 30, 2019
From: REGENEREX LLC
To: TALARIS THERAPEUTICS, INC.
Reel/Frame 050246/0093 →
Change of Name
Aug 30, 2019
From: REGENEREX LLC
To: REGENEREX, INC.
Reel/Frame 050246/0079 →
Change of Name
Dec 17, 2020
From: REGENEREX, INC.
To: TALARIS THERAPEUTICS, INC.
Reel/Frame 054794/0695 →
Transfer of Ownership.
Dec 30, 2025
From: TALARIS THERAPEUTICS, INC.
To: IMMUNOFREE, INC.
Reel/Frame 073455/0819 →